Cancer Center A Cancer Center Designated by
the National Cancer Institute

Clinical Trials in the Category "Head and Neck Neoplasms"

Drug Intervention Trials that are Recruiting

Study Title
Principal Investigator Disease Category
Phase II Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy Quynh-Thu Le
Head and Neck Cancer
Carcinoma, Squamous Cell
BIBW 2992 in Head&Neck Cancer Dr. A. Dimitrios Colevas
Head and Neck Cancer
Carcinoma, Squamous Cell
Phase 3 Efficacy Study of XL184 in Adults With Medullary Thyroid Cancer Dr. A. Dimitrios Colevas
Neuroendocrine Tumors
Thyroid Cancer
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Harlan Pinto
Head and Neck Cancer
Docetaxel, Cisplatin, Fluorouracil, Bevacizumab, and Radiation Therapy in Treating Patients With Advanced Nasopharyngeal Carcinoma Dr. A. Dimitrios Colevas
Head and Neck Cancer
Chemotherapy and Radiation Therapy With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer Quynh-Thu Le
Head and Neck Cancer

Device Intervention Trials that are Recruiting

Study Title
Principal Investigator Disease Category
Assessing the da Vinci® Robotic Surgical System for sugery of the upper aerodigestive tract Edward J. Damrose MD, FACS
Hypopharyngeal Neoplasms
Laryngeal Neoplasms

Other Trials that are Recruiting

Study Title
Principal Investigator Disease Category
Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck Cancer Quynh-Thu Le
Head and Neck Cancer
MRI Imaging of the Human Larynx Edward J. Damrose MD, FACS
Laryngeal Neoplasms
Identification of Secreted Markers for Tumor Hypoxia in Patients with Head and Neck or Lung Cancers Quynh-Thu Le
Head and Neck Cancer
Lip Neoplasms
Lip Cancer
Lung Cancer
Identification and Characterization of Novel Proteins in Head and Neck Cancer Quynh-Thu Le
Head and Neck Cancer
Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample Irene L. Wapnir
Breast Cancer
Salivary Gland Neoplasms
Stomach Cancer
Thyroid Cancer
Biopsy of human tumors for cancer stem cell characterization: a feasibility study Dr. A. Dimitrios Colevas
Head and Neck Cancer
Clinical and Pathologic Studies of Patients Undergoing Treatment with EGFR Inhibitors George Albert Fisher M.D. Ph.D.
Russell Pachynski
Head and Neck Cancer
Colorectal Neoplasms
Anal, Colon, and Rectal Cancers
Colonic Neoplasms
Lung Cancer
Colon Cancer

Trials not Recruiting

Study Title
Principal Investigator Disease Category
Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
(No longer recruiting)
Quynh-Thu Le
haryngeal Neoplasms
A Phase 2 Clinical Trial of the Effectiveness of IRX-2 in Treating Patients With Operable Head and Neck Cancer
(No longer recruiting)
Dr Michael Kaplan
Head and Neck Cancer
Carcinoma, Squamous Cell
Docetaxel With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
(No longer recruiting)
Harlan Pinto
Head and Neck Cancer
Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer
(No longer recruiting)
Daniel T Chang
Esophageal Neoplasms
Adenocarcinoma
Carcinoma, Squamous Cell
Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck
(Completed)
Quynh-Thu Le
Head and Neck Cancer
Carcinoma, Squamous Cell
Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation
(No longer recruiting)
Quynh-Thu Le
Dr. Billy W. Loo Jr. M.D. Ph.D.
Head and Neck Cancer
Carcinoma, Squamous Cell
Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast
(Completed)
Quynh-Thu Le
Dr. Billy W. Loo Jr. M.D. Ph.D.
Head and Neck Cancer
The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers
(Completed)
Quynh-Thu Le
Head and Neck Cancer
Treatment Outcomes and Quality of Life after IMRT Treatments of Head and Neck Cancers
(No longer recruiting)
Quynh-Thu Le
Head and Neck Cancer
Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 whole body scintigraphy for recurrent thyroid CA
(No longer recruiting)
Iain Ross McDougall
Andrei Iagaru
Thyroid Cancer
Endoscopic Capillary Oximetry for Tumor Diagnosis in Head and Neck Cancer
(No longer recruiting)
Peter Maxim PhD
Head and Neck Cancer
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
(No longer recruiting)
Quynh-Thu Le
Head and Neck Cancer
Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck
(Completed)
Dr. A. Dimitrios Colevas
Head and Neck Cancer
Carcinoma, Squamous Cell


The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials.  Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials.

Stanford Medicine Resources:

Footer Links: